Regenxbio
RGNX
168 hedge funds and large institutions have $1.04B invested in Regenxbio in 2019 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 72 increasing their positions, 54 reducing their positions, and 33 closing their positions.
33% more repeat investments, than reductions
Existing positions increased: 72 | Existing positions reduced: 54
20% more call options, than puts
Call options by funds: $7.94M | Put options by funds: $6.61M
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
0.94% less ownership
Funds ownership: 80.4% → 79.46% (-0.94%)
10% less funds holding
Funds holding: 186 → 168 (-18)
31% less capital invested
Capital invested by funds: $1.51B → $1.04B (-$470M)
55% less first-time investments, than exits
New positions opened: 15 | Existing positions closed: 33
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RG
Redmile Group
San Francisco,
California
|
+$39.3M |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$10.2M |
| 3 |
HA
HHLR Advisors
Grand Cayman,
Cayman Islands
|
+$10.1M |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$4.96M |
| 5 |
BlackRock
New York
|
+$4.15M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$18M |
| 2 |
PA
Perceptive Advisors
New York
|
-$14.7M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$10.5M |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
-$7.83M |
| 5 |
Bank of New York Mellon
New York
|
-$6.01M |
RGNX Hedge Fund Activity: Q3 2019 in Review
168 of the 4,574 institutional investors tracked by Wall St. Rank reported a position in Regenxbio (RGNX) for Q3 2019, worth a combined $1.04B — down 31% from $1.51B a quarter earlier.
Sellers outnumbered buyers: 33 funds closed out of RGNX and 15 opened new positions — a net loss of 18 holders — while 54 trimmed existing stakes and 72 added.
The largest buyer was Redmile Group, adding an estimated $39.3M. The largest seller was Renaissance Technologies, exiting entirely with an estimated $18M sold.
- 168 institutional investors held Regenxbio (RGNX) as of Q3 2019, down from 186 in Q2 2019.
- Funds reported $1.04B of Regenxbio stock for Q3 2019, down 31% quarter-over-quarter.
- 15 funds opened new Regenxbio positions in Q3 2019 and 33 closed out, a net change of -18 holders.
- The largest Regenxbio buyer in Q3 2019 was Redmile Group, an estimated $39.3M added.
- The largest Regenxbio seller in Q3 2019 was Renaissance Technologies, an estimated $18M sold.
Based on aggregated 13F filings for Q3 2019.